Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Bacterial Infections and Mycoses

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 179 articles:
HTML format



Single Articles


    June 2021
  1. DESHPANDE AA, Sharma V, Bansal R, Jagia P, et al
    Tension pericardial abscess in a patient with tuberculosis: a rare cause of cardiac tamponade.
    Lancet. 2021;397:e15.
    PubMed    


    May 2021
  2. MAKONI M
    Africa's need for more COVID-19 clinical trials.
    Lancet. 2021;397:2037.
    PubMed    


    April 2021
  3. WALTER KS, Martinez L, Arakaki-Sanchez D, Sequera VG, et al
    The escalating tuberculosis crisis in central and South American prisons.
    Lancet. 2021 Apr 8. pii: S0140-6736(20)32578.
    PubMed     Abstract available


    March 2021
  4. NKEREUWEM E, Kampmann B, Togun T
    The need to prioritise childhood tuberculosis case detection.
    Lancet. 2021 Mar 22. pii: S0140-6736(21)00672.
    PubMed    


  5. LANE R
    Nicole Salazar-Austin: emerging tuberculosis-HIV research leader.
    Lancet. 2021 Mar 18. pii: S0140-6736(21)00587.
    PubMed    


  6. KHO SS, Ho YF, Chan SK, Tie ST, et al
    Mediastinal melioidosis masquerading as malignancy of the lung.
    Lancet. 2021;397:e8.
    PubMed    


    February 2021
  7. MAERTENS JA, Rahav G, Lee DG, Ponce-de-Leon A, et al
    Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial.
    Lancet. 2021;397:499-509.
    PubMed     Abstract available


  8. THORNTON J
    Hopes for trachoma control in South Sudan.
    Lancet. 2021;397:461.
    PubMed    


    January 2021
  9. MACLEAN E, Bigio J, Singh U, Klinton JS, et al
    Global tuberculosis awards must do better with equity, diversity, and inclusion.
    Lancet. 2021;397:192-193.
    PubMed    


    November 2020
  10. GILBERT L, Miller K, Medeiros D, Tsatoumas M, et al
    A disease disregards anatomical planes: actinomycosis and an intrauterine device.
    Lancet. 2020;396:1766.
    PubMed    


  11. FORD AC, Mahadeva S, Carbone MF, Lacy BE, et al
    Functional dyspepsia.
    Lancet. 2020;396:1689-1702.
    PubMed     Abstract available


    September 2020
  12. BURKI T
    Inappropriate behaviour claims at Stop TB prompt review.
    Lancet. 2020;396:876.
    PubMed    


  13. JONES D, Helmreich S
    A history of herd immunity.
    Lancet. 2020;396:810-811.
    PubMed    


  14. DE BENEDICTIS FM, Kerem E, Chang AB, Colin AA, et al
    Complicated pneumonia in children.
    Lancet. 2020;396:786-798.
    PubMed     Abstract available


    August 2020
  15. BISSON GP, Bastos M, Campbell JR, Bang D, et al
    Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis.
    Lancet. 2020;396:402-411.
    PubMed     Abstract available


    June 2020
  16. LADHANI SN, Lucidarme J, Parikh SR, Campbell H, et al
    Meningococcal disease and sexual transmission: urogenital and anorectal infections and invasive disease due to Neisseria meningitidis.
    Lancet. 2020;395:1865-1877.
    PubMed     Abstract available


  17. WITHINGTON P
    Journal of a plague year.
    Lancet. 2020;395:1754-1755.
    PubMed    


    May 2020
  18. BATE J
    The worst is not, so long as we can say "this is the worst".
    Lancet. 2020;395:1479-1480.
    PubMed    


    April 2020
  19. THORNHILL MH, Dayer MJ, Nicholl J, Prendergast BD, et al
    An alarming rise in incidence of infective endocarditis in England since 2009: why?
    Lancet. 2020;395:1325-1327.
    PubMed    



  20. Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3.
    Lancet. 2020 Apr 23. pii: S0140-6736(20)30608.
    PubMed     Abstract available


  21. SUNDEWALL J, Forsberg BC
    Understanding health spending for SDG 3.
    Lancet. 2020 Apr 23. pii: S0140-6736(20)30963.
    PubMed    


  22. THE LANCET
    A new roadmap for meningitis.
    Lancet. 2020;395:1230.
    PubMed    


  23. JOHNSON PDR
    Buruli ulcer: cured by 8 weeks of oral antibiotics?
    Lancet. 2020;395:1231-1232.
    PubMed    


  24. PHILLIPS RO, Robert J, Abass KM, Thompson W, et al
    Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial.
    Lancet. 2020;395:1259-1267.
    PubMed     Abstract available


  25. BOYCE N
    Bills of Mortality: tracking disease in early modern London.
    Lancet. 2020;395:1186-1187.
    PubMed    


    March 2020
  26. MARTINEZ L, Cords O, Horsburgh CR, Andrews JR, et al
    The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis.
    Lancet. 2020;395:973-984.
    PubMed     Abstract available


  27. SAHU S, Ditiu L, Lawson L, Ntoumi F, et al
    UN General Assembly tuberculosis targets: are we on track?
    Lancet. 2020;395:928-930.
    PubMed    


  28. CAMPBELL JR, Bastos ML
    No time to waste: preventing tuberculosis in children.
    Lancet. 2020;395:924-926.
    PubMed    


  29. KIM HY, Heysell SK, Mpagama S, Marais BJ, et al
    Challenging the management of drug-resistant tuberculosis.
    Lancet. 2020;395:783.
    PubMed    


  30. LANGE C, Dheda K, Chesov D, Mandalakas AM, et al
    Challenging the management of drug-resistant tuberculosis - Authors' reply.
    Lancet. 2020;395:783-784.
    PubMed    


  31. GASKELL KM, Moore DAJ
    Challenging the management of drug-resistant tuberculosis.
    Lancet. 2020;395:782-783.
    PubMed    


    February 2020
  32. DESGRANGES F, Coste AT, Wernly D, Dufour J, et al
    Immunosuppressed gardener pricked by roses grows Legionella longbeachae.
    Lancet. 2020;395:604.
    PubMed    


  33. LANE R
    Hans Kluge: charismatic, new WHO Regional Director for Europe.
    Lancet. 2020;395:329.
    PubMed    


    January 2020
  34. ALLEGRETTI JR, Mullish BH
    Faecal microbiota transplantations and urinary tract infections - Authors' reply.
    Lancet. 2020;395:271.
    PubMed    


    November 2019
  35. MAKRI A
    Progress lags on vaccines to beat antimicrobial resistance.
    Lancet. 2019;394:1793-1794.
    PubMed    


  36. WATTS N, Amann M, Arnell N, Ayeb-Karlsson S, et al
    The 2019 report of The Lancet Countdown on health and climate change: ensuring that the health of a child born today is not defined by a changing climate.
    Lancet. 2019;394:1836-1878.
    PubMed    


  37. VARO R, Bila R, Saavedra B, Sitoe A, et al
    Paraplegia and spinal deformity in a Mozambican child with Pott's disease and tuberculous scrofula.
    Lancet. 2019;394:1651.
    PubMed    


    October 2019
  38. THE LANCET
    End the tuberculosis emergency: a promise is not enough.
    Lancet. 2019;394:1482.
    PubMed    


  39. SINGER M, Inada-Kim M, Shankar-Hari M
    Sepsis hysteria: excess hype and unrealistic expectations.
    Lancet. 2019;394:1513-1514.
    PubMed    


  40. MALLUCCI CL, Jenkinson MD, Conroy EJ, Hartley JC, et al
    Antibiotic or silver versus standard ventriculoperitoneal shunts (BASICS): a multicentre, single-blinded, randomised trial and economic evaluation.
    Lancet. 2019;394:1530-1539.
    PubMed     Abstract available


  41. RAY S, Anand K
    Reduce the delay in tuberculosis diagnosis in India.
    Lancet. 2019 Oct 24. pii: S0140-6736(19)32476.
    PubMed    


  42. THANGARAJU P, Venkatesan S
    A double blow for a patient with leprosy: a reversal reaction and an adverse drug reaction.
    Lancet. 2019;394:1450.
    PubMed    


  43. MAHARAJ S, Seemungal T, McKee M
    A perfect storm in the Caribbean requires a concerted response.
    Lancet. 2019;394:1409.
    PubMed    


  44. TCHIOMBIANO S, Delfraissy JF, Dabis F
    The Global Fund's Sixth Replenishment Conference: a challenge for France, a challenge for global health.
    Lancet. 2019;394:1214-1215.
    PubMed    


    September 2019
  45. KOKO AM, Ismail NJ, Lasseini A, Shehu BB, et al
    Remarkable recovery in an infant with brain abscesses.
    Lancet. 2019;394:1191.
    PubMed    


  46. REUTER A, Hughes J, Furin J
    Challenges and controversies in childhood tuberculosis.
    Lancet. 2019;394:967-978.
    PubMed     Abstract available


  47. LANGE C, Dheda K, Chesov D, Mandalakas AM, et al
    Management of drug-resistant tuberculosis.
    Lancet. 2019;394:953-966.
    PubMed     Abstract available


  48. THE LANCET
    Tuberculosis needs accelerated and continued attention.
    Lancet. 2019;394:896.
    PubMed    


  49. KOSKENVUO L, Lehtonen T, Koskensalo S, Rasilainen S, et al
    Mechanical and oral antibiotic bowel preparation versus no bowel preparation for elective colectomy (MOBILE): a multicentre, randomised, parallel, single-blinded trial.
    Lancet. 2019;394:840-848.
    PubMed     Abstract available


    August 2019
  50. HAGHBAYAN H, Ballios BG, Coomes EA
    Management of rheumatic mitral stenosis.
    Lancet. 2019;394:637.
    PubMed    


  51. MCCARRON EP, Monaghan M, Sreenivasan S
    Management of rheumatic mitral stenosis.
    Lancet. 2019;394:636-637.
    PubMed    


  52. REID MJA, Goosby E
    A tuberculosis-free world: is it a delusion? - Authors' reply.
    Lancet. 2019 Aug 12. pii: S0140-6736(19)31411.
    PubMed    


  53. ATRE S
    A tuberculosis-free world: is it a delusion?
    Lancet. 2019 Aug 12. pii: S0140-6736(19)31623.
    PubMed    


  54. ALLEGRETTI JR, Mullish BH, Kelly C, Fischer M, et al
    The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications.
    Lancet. 2019;394:420-431.
    PubMed     Abstract available


  55. OLIVIER-GOUGENHEIM L, Freychet C, Collardeau-Frachon S, Roure-Sobas C, et al
    A quest for Q fever.
    Lancet. 2019;394:419.
    PubMed    


  56. THE LANCET
    Building capacity in Africa's national science academies.
    Lancet. 2019;394:360.
    PubMed    


    July 2019
  57. BASHAM CA, Elias B, Orr P
    Tuberculosis elimination in Canada.
    Lancet. 2019;394:300-301.
    PubMed    


  58. MENZIES D, Benedetti A, Migliori GB, Nahid P, et al
    Multidrug-resistant tuberculosis - Authors' reply.
    Lancet. 2019;394:299-300.
    PubMed    


  59. CHIANG CY, Van Deun A, Trebucq A, Piubello A, et al
    Multidrug-resistant tuberculosis.
    Lancet. 2019;394:299.
    PubMed    


  60. CAMINERO JA, Garcia-Basteiro AL, Rendon A
    Multidrug-resistant tuberculosis.
    Lancet. 2019;394:298.
    PubMed    


  61. NYANG'WA BT, Berry C, Fielding K, Nunn AJ, et al
    Multidrug-resistant tuberculosis.
    Lancet. 2019;394:298-299.
    PubMed    


  62. CARLSON CJ, Mendenhall E
    Preparing for emerging infections means expecting new syndemics.
    Lancet. 2019;394:297.
    PubMed    


  63. LAVOIE PM, Popescu CR, Molyneux EM, Wynn JL, et al
    Rethinking management of neonates at risk of sepsis.
    Lancet. 2019;394:279-281.
    PubMed    


  64. MOAZEN B, Assari S, Neuhann F, Stover H, et al
    The guidelines on infection control in prisons need revising.
    Lancet. 2019;394:301-302.
    PubMed    


  65. WANG HH, Lau E, Horton R, Jiang B, et al
    The Wakley-Wu Lien Teh Prize Essay 2019: telling the stories of Chinese doctors.
    Lancet. 2019;394:11.
    PubMed    


    June 2019

  66. Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study.
    Lancet. 2019 Jun 27. pii: S0140-6736(19)30721.
    PubMed     Abstract available


  67. KNIGHT M, Chiocchia V, Partlett C, Rivero-Arias O, et al
    Prophylactic antibiotics in the prevention of infection after operative vaginal delivery (ANODE): a multicentre randomised controlled trial.
    Lancet. 2019;393:2395-2403.
    PubMed     Abstract available


  68. MORI Y, Katasako A, Matsunaga S, Matono T, et al
    Tetanus: remember to vaccinate.
    Lancet. 2019;393:2331.
    PubMed    


    May 2019
  69. RYAN JM, Feder HM Jr
    Dog licks baby. Baby gets Pasteurella multocida meningitis.
    Lancet. 2019;393:e41.
    PubMed    


  70. USHER AD
    Low-cost pneumonia vaccine breaks into global market.
    Lancet. 2019;393:2025-2026.
    PubMed    


  71. FRIEBEL R, Silverman R, Glassman A, Chalkidou K, et al
    On results reporting and evidentiary standards: spotlight on the Global Fund.
    Lancet. 2019;393:2006-2008.
    PubMed    


  72. KIRKCALDY RD, Workowski KA
    Gentamicin as an alternative treatment for gonorrhoea.
    Lancet. 2019 May 2. pii: S0140-6736(19)30244.
    PubMed    


  73. ROSS JDC, Brittain C, Cole M, Dewsnap C, et al
    Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial.
    Lancet. 2019 May 2. pii: S0140-6736(18)32817.
    PubMed     Abstract available


    April 2019
  74. ZHONG D, Yi Y, Lin C
    A kidney changes size: first increasing and then decreasing.
    Lancet. 2019;393:1641.
    PubMed    


  75. YEN LM, Thwaites CL
    Tetanus.
    Lancet. 2019;393:1657-1668.
    PubMed     Abstract available


  76. KLUGMAN KP, Rodgers GL
    Population versus individual protection by pneumococcal conjugate vaccination.
    Lancet. 2019 Apr 15. pii: S0140-6736(19)30039.
    PubMed    


  77. HAMMITT LL, Etyang AO, Morpeth SC, Ojal J, et al
    Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study.
    Lancet. 2019 Apr 15. pii: S0140-6736(18)33005.
    PubMed     Abstract available


  78. PAN D, Arkell P, Stone NRH, Parkinson B, et al
    Delayed Strongyloides stercoralis hyperinfection syndrome in a renal transplant patient with Pneumocystis jirovecii pneumonia receiving high-dose corticosteroids.
    Lancet. 2019;393:1536.
    PubMed    


  79. HONIGSBAUM M
    Disease X and other unknowns.
    Lancet. 2019;393:1496-1497.
    PubMed    


    March 2019
  80. ABUBAKAR I, Plasencia A, Barnighausen T, Froeschl G, et al
    Horizon Europe: towards a European agenda for global health research and innovation.
    Lancet. 2019;393:1272-1273.
    PubMed    


  81. MIMOZ O, Guenezan J
    No benefit of chlorhexidine bathing in non-critical care units.
    Lancet. 2019;393:1179-1180.
    PubMed    


  82. HUANG SS, Septimus E, Kleinman K, Moody J, et al
    Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): a cluster-randomised trial.
    Lancet. 2019;393:1205-1215.
    PubMed     Abstract available


  83. ZUCCALA E, Horton R
    Time to bring tuberculosis out of the shadows.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30486.
    PubMed    


  84. KI-MOON B
    Building a tuberculosis-free world on a foundation of universal health coverage.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30433.
    PubMed    


  85. ZAROCOSTAS J
    Nandita Venkatesan: a voice of hope for tuberculosis survivors.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30582.
    PubMed    


  86. NADDA JP
    India's leadership to end tuberculosis.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30487.
    PubMed    


  87. KUMAR A
    Picturing health: it's time to act on tuberculosis.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30583.
    PubMed    


  88. WEBSTER P
    Inuit research raises concerns about tuberculosis eradication.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30681.
    PubMed    


  89. REID MJA, Arinaminpathy N, Bloom A, Bloom BR, et al
    Building a tuberculosis-free world: The Lancet Commission on tuberculosis.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30024.
    PubMed    


  90. FURIN J, Cox H, Pai M
    Tuberculosis.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30308.
    PubMed     Abstract available


  91. WATTS G
    Christine Sekaggya-Wiltshire: prizewinner in HIV-tuberculosis research.
    Lancet. 2019 Mar 19. pii: S0140-6736(19)30644.
    PubMed    


  92. FADEL SA, Boschi-Pinto C, Yu S, Reynales-Shigematsu LM, et al
    Trends in cause-specific mortality among children aged 5-14 years from 2005 to 2016 in India, China, Brazil, and Mexico: an analysis of nationally representative mortality studies.
    Lancet. 2019;393:1119-1127.
    PubMed     Abstract available


  93. AZZOPARDI PS, Hearps SJC, Francis KL, Kennedy EC, et al
    Progress in adolescent health and wellbeing: tracking 12 headline indicators for 195 countries and territories, 1990-2016.
    Lancet. 2019;393:1101-1118.
    PubMed     Abstract available


  94. PAGE KR, Doocy S, Reyna Ganteaume F, Castro JS, et al
    Venezuela's public health crisis: a regional emergency.
    Lancet. 2019 Mar 11. pii: S0140-6736(19)30344.
    PubMed     Abstract available


  95. OLMEDO-RENEAUM A, Garcia-Juarez I, Toapanta-Yanchapaxi L, De La Pena-Lopez R, et al
    Rogue "stem cell clinic" leads to Mycobacterium abscessus infection.
    Lancet. 2019;393:918.
    PubMed    


    February 2019
  96. STORY A, Aldridge RW, Smith CM, Garber E, et al
    Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial.
    Lancet. 2019 Feb 21. pii: S0140-6736(18)32993.
    PubMed     Abstract available


  97. FRASER H, Keshavjee S
    Video-observed therapy for tuberculosis: strengthening care.
    Lancet. 2019 Feb 21. pii: S0140-6736(19)30293.
    PubMed    


  98. KUMAR A, Lambert S, Lockwood DNJ
    Picturing health: a new face for leprosy.
    Lancet. 2019;393:629-638.
    PubMed    


  99. THE LANCET
    Abandoning the stigma of leprosy.
    Lancet. 2019;393:378.
    PubMed    


  100. GOSTIN L, Phelan A, Coutinho AG, Eccleston-Turner M, et al
    Ebola in the Democratic Republic of the Congo: time to sound a global alert?
    Lancet. 2019 Feb 1. pii: S0140-6736(19)30243.
    PubMed    


    January 2019
  101. CHEKHCHAR M, Hajji I, Madiq B, Darfaoui Z, et al
    Mitral stenosis found after eye problem.
    Lancet. 2019;393:275.
    PubMed    


  102. BARNETT R
    Cholera.
    Lancet. 2019;393:218.
    PubMed    



  103. Enteral lactoferrin supplementation for very preterm infants: a randomised placebo-controlled trial.
    Lancet. 2019 Jan 8. pii: S0140-6736(18)32221.
    PubMed     Abstract available


  104. DOYLE LW, Cheong JLY
    Does bovine lactoferrin prevent late-onset neonatal sepsis?
    Lancet. 2019 Jan 8. pii: S0140-6736(18)32390.
    PubMed    


  105. FERRY G
    Dorothy Stopford Price and the control of tuberculosis in Ireland.
    Lancet. 2019;393:20.
    PubMed    


    December 2018
  106. SAVIOLI L, Daumerie D
    WHO leadership is essential for the elimination of NTDs.
    Lancet. 2018;390:2765.
    PubMed    


  107. YAQUB F
    2017: a year in review.
    Lancet. 2018;390:2753-2754.
    PubMed    


  108. THE LANCET
    Our responsibility to protect the Rohingya.
    Lancet. 2018;390:2740.
    PubMed    


  109. BLUMENTHAL KG, Peter JG, Trubiano JA, Phillips EJ, et al
    Antibiotic allergy.
    Lancet. 2018 Dec 14. pii: S0140-6736(18)32218.
    PubMed     Abstract available


  110. OLSAVSZKY V, Geraud C
    Liaison leads to solitary syphilitic chancre on the neck.
    Lancet. 2018;392:2397.
    PubMed    


  111. VAN DER HEIJDE D, Baraliakos X, Gensler LS, Maksymowych WP, et al
    Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial.
    Lancet. 2018;392:2378-2387.
    PubMed     Abstract available


  112. MEASE P, Coates LC, Helliwell PS, Stanislavchuk M, et al
    Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial.
    Lancet. 2018;392:2367-2377.
    PubMed     Abstract available


  113. MBONYE AK, Sekamatte M
    Disease outbreaks and reporting in Uganda.
    Lancet. 2018;392:2347-2348.
    PubMed    


    November 2018

  114. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    Lancet. 2018;392:1859-1922.
    PubMed     Abstract available


  115. MARMORA L, Casas CP, Grubb I, McClure C, et al
    Long-acting technologies for infectious diseases in LMICs.
    Lancet. 2018;392:1610-1611.
    PubMed    


  116. GRANICH R
    Is the global tuberculosis control strategy too big to fail?
    Lancet. 2018 Nov 1. pii: S0140-6736(18)32751.
    PubMed    


    October 2018
  117. HOCKING JS, Temple-Smith M, Guy R, Donovan B, et al
    Population effectiveness of opportunistic chlamydia testing in primary care in Australia: a cluster-randomised controlled trial.
    Lancet. 2018;392:1413-1422.
    PubMed     Abstract available


  118. ADAMSON PC, Klausner JD
    No benefit of chlamydia screening in primary care?
    Lancet. 2018;392:1381-1383.
    PubMed    


  119. MARKS F, Kim JH, Rakotozandrindrainy R
    Madagascar should introduce typhoid conjugate vaccines now.
    Lancet. 2018;392:1309-1310.
    PubMed    


  120. KLEBANOFF MA, Brotman RM
    Treatment of bacterial vaginosis to prevent preterm birth.
    Lancet. 2018 Oct 12. pii: S0140-6736(18)32115.
    PubMed    


  121. SUBTIL D, Brabant G, Tilloy E, Devos P, et al
    Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial.
    Lancet. 2018 Oct 12. pii: S0140-6736(18)31617.
    PubMed     Abstract available


  122. THE LANCET
    Congenital syphilis in the USA.
    Lancet. 2018;392:1168.
    PubMed    


  123. COUSINS S
    UN High-Level meeting to end tuberculosis disappointing.
    Lancet. 2018 Oct 3. pii: S0140-6736(18)32458.
    PubMed    


    September 2018
  124. MAKONI M
    Inside Zimbabwe's efforts to tame cholera.
    Lancet. 2018;392:e8.
    PubMed    


  125. MARAIS B, Zumla A
    Advancing global tuberculosis control after the UNGA-HLM.
    Lancet. 2018 Sep 24. pii: S0140-6736(18)32361.
    PubMed    


  126. THE LANCET
    Monkeypox contacts: a puzzling problem.
    Lancet. 2018;392:986.
    PubMed    


  127. TRIPATHI M, Mohindra S
    Rhinocerebral aspergillosis.
    Lancet. 2018;392:e8.
    PubMed    


  128. AHMAD N, Ahuja SD, Akkerman OW, Alffenaar JC, et al
    Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.
    Lancet. 2018;392:821-834.
    PubMed     Abstract available


  129. FARMER PE
    Better and safer treatment for multidrug-resistant tuberculosis.
    Lancet. 2018;392:798-800.
    PubMed    


  130. REUTER A, Furin J
    Reducing harm in the treatment of multidrug-resistant tuberculosis.
    Lancet. 2018;392:797-798.
    PubMed    


    August 2018
  131. COUSINS S
    Experts fear a resurgence of leprosy in India.
    Lancet. 2018;392:624-625.
    PubMed    


  132. THWAITES GE, Szubert A, Walker AS
    Rifampicin in treating S aureus bacteraemia - Authors' reply.
    Lancet. 2018;392:555-556.
    PubMed    


  133. RIEG S, Kern WV, Soriano A
    Rifampicin in treating S aureus bacteraemia.
    Lancet. 2018;392:554-555.
    PubMed    


  134. THE LANCET
    Zika-associated health and development problems in children.
    Lancet. 2018;392:532.
    PubMed    


  135. MBOI N, Murty Surbakti I, Trihandini I, Elyazar I, et al
    On the road to universal health care in Indonesia, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    Lancet. 2018;392:581-591.
    PubMed     Abstract available


  136. BURZA S, Croft SL, Boelaert M
    Leishmaniasis.
    Lancet. 2018 Aug 17. pii: S0140-6736(18)31204.
    PubMed     Abstract available


  137. GARBARINO MC, Cani V, Mazzarello P
    A century ago: Carlo Forlanini and the first successful treatment of tuberculosis.
    Lancet. 2018;392:475.
    PubMed    


  138. THE LANCET
    Introducing EU-wide surveillance of Lyme neuroborreliosis.
    Lancet. 2018;392:452.
    PubMed    


    July 2018
  139. WALLACE DJ, Furie RA, Tanaka Y, Kalunian KC, et al
    Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial.
    Lancet. 2018;392:222-231.
    PubMed     Abstract available


  140. GUPTA-WRIGHT A, Corbett EL, van Oosterhout JJ, Wilson D, et al
    Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31267.
    PubMed     Abstract available


  141. NATHAVITHARANA RR, Pai M
    New strategies for inpatients with HIV and tuberculosis.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31442.
    PubMed    


  142. SEALE AC, Agarwal R
    Improving management of neonatal infections.
    Lancet. 2018;392:100-102.
    PubMed    


  143. KARTHIKEYAN G, Guilherme L
    Acute rheumatic fever.
    Lancet. 2018;392:161-174.
    PubMed     Abstract available


  144. SAHA SK, Schrag SJ, El Arifeen S, Mullany LC, et al
    Causes and incidence of community-acquired serious infections among young children in south Asia (ANISA): an observational cohort study.
    Lancet. 2018;392:145-159.
    PubMed     Abstract available


    June 2018
  145. KRAEF C, Arand J, Veletzky L, Schafer H, et al
    Schistosomiasis detected during appendectomy.
    Lancet. 2018;391:2546.
    PubMed    


  146. CECCONI M, Evans L, Levy M, Rhodes A, et al
    Sepsis and septic shock.
    Lancet. 2018 Jun 21. pii: S0140-6736(18)30696.
    PubMed     Abstract available


  147. XIE X, Bai J
    Concentric circles in left atrium.
    Lancet. 2018;391:2448.
    PubMed    


  148. SALAMA PJ, Embarek PKB, Bagaria J, Fall IS, et al
    Learning from listeria: safer food for all.
    Lancet. 2018;391:2305-2306.
    PubMed    


  149. THE LANCET
    Active case finding for communicable diseases in prisons.
    Lancet. 2018;391:2186.
    PubMed    



  150. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016.
    Lancet. 2018;391:2236-2271.
    PubMed     Abstract available


    May 2018
  151. CHATTOPADHYAY A, Sharma A, Gupta K, Jain S, et al
    The Phemister triad.
    Lancet. 2018;391:e20.
    PubMed    


  152. THE LANCET
    Balancing treatment with resistance in UTIs.
    Lancet. 2018;391:1966.
    PubMed    


  153. QADRI F, Azad AK, Flora MS, Khan AI, et al
    Emergency deployment of oral cholera vaccine for the Rohingya in Bangladesh.
    Lancet. 2018;391:1877-1879.
    PubMed    


  154. LESSLER J, Moore SM, Luquero FJ, McKay HS, et al
    Mapping the burden of cholera in sub-Saharan Africa and implications for control: an analysis of data across geographical scales.
    Lancet. 2018;391:1908-1915.
    PubMed     Abstract available


  155. MINTZ E
    Taking aim at cholera.
    Lancet. 2018;391:1868-1870.
    PubMed    


  156. COUSINS S
    Managing MDR tuberculosis in Nepal.
    Lancet. 2018;391:1760-1761.
    PubMed    


  157. GUENOT M
    Roger Glass: celebrating the Fogarty at 50.
    Lancet. 2018;391:1765.
    PubMed    


    April 2018
  158. CHU DK, Kim LH, Young PJ, Zamiri N, et al
    Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis.
    Lancet. 2018;391:1693-1705.
    PubMed     Abstract available


  159. COSTELLO A
    The Global Fund links with Lombard Odier bank.
    Lancet. 2018;391:1674-1675.
    PubMed    


  160. MITJA O, Godornes C, Houinei W, Kapa A, et al
    Re-emergence of yaws after single mass azithromycin treatment followed by targeted treatment: a longitudinal study.
    Lancet. 2018;391:1599-1607.
    PubMed     Abstract available


  161. BARNETT R
    Syphilis.
    Lancet. 2018;391:1471.
    PubMed    


    March 2018
  162. PARK KB, Khan U, Seung K
    Open letter to The Global Fund about its decision to end DPRK grants.
    Lancet. 2018;391:1257.
    PubMed    


  163. SHARMA D
    Commitments to an end to tuberculosis renewed in India.
    Lancet. 2018;391:1138.
    PubMed    


  164. GOOSBY E, Jamison D, Swaminathan S, Reid M, et al
    The Lancet Commission on tuberculosis: building a tuberculosis-free world.
    Lancet. 2018;391:1132-1133.
    PubMed    


  165. WINGFIELD T, Tovar MA, Datta S, Saunders MJ, et al
    Addressing social determinants to end tuberculosis.
    Lancet. 2018;391:1129-1132.
    PubMed    


  166. DAVIES R
    Leo Martinez: striving to end childhood tuberculosis.
    Lancet. 2018 Mar 21. pii: S0140-6736(18)30680.
    PubMed    


  167. MCCALL C
    Rheumatic heart disease in the Pacific island nations.
    Lancet. 2018;391:926.
    PubMed    


    February 2018
  168. BURKI T
    End of a cholera epidemic in South Sudan declared.
    Lancet. 2018;391:647.
    PubMed    


  169. MUHSEN K, Green MS, Soskolne V, Neumark Y, et al
    Inequalities in non-communicable diseases in Israel - Authors' reply.
    Lancet. 2018;391:537.
    PubMed    


  170. WATTS N, Amann M, Ayeb-Karlsson S, Belesova K, et al
    The Lancet Countdown on health and climate change: from 25 years of inaction to a global transformation for public health.
    Lancet. 2018;391:581-630.
    PubMed    


  171. SMAJS D, Pospisilova P
    Macrolide resistance in yaws.
    Lancet. 2018 Feb 7. pii: S0140-6736(18)30205.
    PubMed    


  172. HONIGSBAUM M
    Superbugs and us.
    Lancet. 2018;391:420.
    PubMed    


    January 2018
  173. ZAROCOSTAS J
    Mega-crisis in DR Congo.
    Lancet. 2018;391:297-298.
    PubMed    


  174. THE LANCET
    A new vaccine for typhoid control.
    Lancet. 2018;391:96.
    PubMed    


  175. THE LANCET
    Tuberculosis: criteria for global leadership?
    Lancet. 2018;391:2.
    PubMed    


    December 2017
  176. HOLLAND TL, Fowler VG Jr
    Rifampicin for Staphylococcus aureus bacteraemia: give it ARREST.
    Lancet. 2017 Dec 14. pii: S0140-6736(17)33294.
    PubMed    


  177. THWAITES GE, Scarborough M, Szubert A, Nsutebu E, et al
    Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial.
    Lancet. 2017 Dec 14. pii: S0140-6736(17)32456.
    PubMed     Abstract available


    September 2017
  178. POKROVSKY V
    Tuberculosis and HIV/AIDS: the alien and the predator.
    Lancet. 2017;390:1618-1619.
    PubMed    


    July 2017
  179. YACOUB M, Mayosi B, ElGuindy A, Carpentier A, et al
    Eliminating acute rheumatic fever and rheumatic heart disease.
    Lancet. 2017;390:212-213.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: